Victor Stone - Profile and Investment Details

Investor Profile

Victor Stone is a Venture Capital, Private Equity Firm, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Enzyre B.V., Takeda, Code Biotherapeutics, Axcelead Drug Discovery Partners, Inc., Whiz Partners, Inc., Adaptate Biotherapeutics, Shonan Health Innovation Park, ARTham Therapeutics (subsidiary of Kaken Pharmaceutical Co Ltd), SynGenSys Limited, Shattuck Labs, . Over time, Victor Stone has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Victor Stone is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Autoimmune Diseases, Wellness, Immunotherapy, Life Science, Engineering, Manufacturing, Biotechnology, Drug Development, Logistics, Medical, B2B, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Victor Stone, as their portfolio suggests a familiarity and interest in this area.

Understanding Victor Stone’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.